Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications?

Practical Radiation Oncology

Volumn 5, Issue 4, 2015, Pages e299-e308

  Ding, Yao ^a   Mohamed, Abdallah S R ^a,b   Yang, Jinzhong ^a   Colen, Rivka R ^a   Frank, Steven J ^a,c   Wang, Jihong ^a,c   Wassal, Eslam Y ^a,d   Wang, Wenjie ^a   Kantor, Michael E ^a   Balter, Peter A ^a,c   Rosenthal, David I ^a   Lai, Stephen Y ^a   Hazle, John D ^a,c   Fuller, Clifton D ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF TEXAS   (United States)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFACT REDUCTION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMMOBILIZATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; PATIENT POSITIONING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; HEAD AND NECK NEOPLASMS; IMAGE GUIDED RADIOTHERAPY; MIDDLE AGED; PATHOLOGY; PROCEDURES; SOFTWARE; STANDARDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT POSITIONING; PROSPECTIVE STUDIES; RADIOTHERAPY, IMAGE-GUIDED; SOFTWARE;

EID: 84937164447     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2014.11.003     Document Type: Article

References (40)

1. Chao K.S., Ozyigit G., Tran B.N., Cengiz M., Dempsey J.F., Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003, 55:312-321.
2. Eisbruch A., Marsh L.H., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004, 59:28-42.
3. Schoenfeld G.O., Amdur R.J., Morris C.G., Li J.G., Hinerman R.W., Mendenhall W.M. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 71:377-385.
4. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000, 46:1117-1126.
5. Madani I., Duthoy W., Derie C., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol 2007, 68:126-135.
6. Madani I., Duprez F., Boterberg T., et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. Radiother Oncol 2011, 101:351-355.
7. Houweling A.C., Wolf A.L., Vogel W.V., et al. FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: Implications for dose painting. Radiother Oncol 2013, 106:250-254.
8. Chang J.H., Wada M., Anderson N.J., et al. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using F-18-FMISO PET: A biological modeling study. Acta Oncol 2013, 52:1723-1729.
9. Berwouts D., Olteanu L.A.M., Duprez F., et al. Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: Initial results of the phase I clinical trial. Radiother Oncol 2013, 107:310-316.
10. Duprez F., De Neve W., De Gersem W., Coghe M., Madani I. Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol 2011, 80:1045-1055.
11. Grosu A., Piert M., Souvatzoglou M., et al. Hypoxia imaging with 18F-FAZA-PET for dose painting using intensity modulated radiotherapy in patients with head and neck cancer. Int J Radiat Oncol 2005, 63(Suppl. 1):S132-S133.
12. Thorwarth D., Eschmann S.M., Paulsen F., Alber M. Hypoxia dose painting based on functional FMISO PET imaging for head-and-neck cancer patients: A feasibility study. Int J Radiat Oncol 2006, 66:S186.
13. Olteanu L.A., Madani I., De Neve W., Vercauteren T., De Gersem W. Evaluation of deformable image coregistration in adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012, 83:696-703.
14. Manon R., Langen K., Meeks S., et al. Clinical application of deformable image registration in head and neck cancer radiotherapy: Does planned dose to tumor and normal structures change during treatment?. Int J Radiat Oncol 2006, 66:S416.
15. Ireland R.H., Dyker K.E., Barber D.C., et al. Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT. Int J Radiat Oncol 2007, 68:952-957.
16. Daisne J.F., Sibomana M., Bol A., Cosnard G., Lonneux M., Grégoire V. Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: Accuracy, reproducibility and consistency. Radiother Oncol 2003, 69:237-245.
17. 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol 2002, 53:1051-1057.
18. Rasch C., Keus R., Pameijer F.A., et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol 1997, 39:841-848.
19. Kim S., Loevner L., Quon H., et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009, 15:986-994.
20. Hatakenaka M., Nakamura K., Yabuuchi H., et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 2011, 81:339-345.
21. Lambrecht M., Van Calster B., Vandecaveye V., et al. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol 2014, 110:429-434.
22. Khoo V.S., Dearnaley D.P., Finnigan D.J., Padhani A., Tanner S.F., Leach M.O. Magnetic resonance imaging (MRI): Considerations and applications in radiotherapy treatment planning. Radiother Oncol 1997, 42:1-15.
23. Walker A., Liney G., Metcalfe P., Holloway L. MRI distortion: Considerations for MRI based radiotherapy treatment planning. Australas Phys Eng Sci Med Mar 2014, 37:103-113.
24. Prabhakar R., Julka P.K., Ganesh T., Munshi A., Joshi R.C., Rath G.K. Feasibility of using MRI alone for 3D radiation treatment planning in brain tumors. Jpn J Clin Oncol 2007, 37:405-411.
25. Crijns S.P.M., Bakker C.J.G., Seevinck P.R., de Leeuw H., Lagendijk J.J.W., Raaymakers B.W. Towards inherently distortion-free MR images for image-guided radiotherapy on an MRI accelerator. Phys Med Biol 2012, 57:1349-1358.
26. Bosca R.J., Jackson E.F., Dong L., Schwartz D.L. Prospective pharmacokinetic and diffusion MRI measurement of normal tissue response to head and neck IMRT. Int J Radiat Oncol 2010, 78(Suppl):S118.
27. Garden A. A pilot trial of image-guided adaptive radiotherapy for head and neck cancer Available at:, Accessed June 13, 2014. https://clinicaltrials.gov/ct2/show/NCT00490282?term=head+neck+garden&rank=3.
28. Frank SJ. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT). Available at:. M.D. Anderson Cancer Center. Accessed June 13, 2014. https://clinicaltrials.gov/ct2/show/NCT01893307?term=head+neck+frank&rank=2.
29. Palmer J., Yang J., Pan T., Court L.E. Motion of the esophagus due to cardiac motion. PloS One 2014, 9:e89126.
30. Wang H., Dong L., Lii M.F., et al. Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005, 61:725-735.
31. Wang H., Dong L., O'Daniel J., et al. Validation of an accelerated "demons" algorithm for deformable image registration in radiation therapy. Phys Med Biol 2005, 50:2887-2905.
32. Verduijn G.M., Bartels L.W., Raaijmakers C.P., Terhaard C.H., Pameijer F.A., van den Berg C.A. Magnetic resonance imaging protocol optimization for delineation of gross tumor volume in hypopharyngeal and laryngeal tumors. Int J Radiat Oncol Biol Phys 2009, 74:630-636.
33. Partridge M., Powell C., Koopman M., Vidan L.H., Newbold K. Technical note: 9-month repositioning accuracy for functional response assessment in head and neck chemoradiotherapy. Br J Radiol 2012, 85:1576-1580.
34. Raaymakers B.W., Lagendijk J.J., Overweg J., et al. Integrating a 1.5 T MRI scanner with a 6 MV accelerator: Proof of concept. Phys Med Biol 2009, 54:N229-N237.
35. Kron T., Eyles D., John S.L., Battista J. Magnetic resonance imaging for adaptive cobalt tomotherapy: A proposal. J Med Phys 2006, 31:242-254.
36. Chen Y., Liu X., Zheng D., et al. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. Magn Reson Imaging 2014, 32:630-637.
37. Marzi S., Forina C., Marucci L., et al. Early radiation-induced changes evaluated by intravoxel incoherent motion in the major salivary glands [e-pub ahead of print]. J Magn Reson Imaging 2014, accessed November 19, 2014. 10.1002/jmri.24626.
38. Lambrecht M., Van Calster B., Vandecaveye V., et al. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol 2014, 110:429-434.
39. Lambrecht M., Van Herck H., De Keyzer F., et al. Redefining the target early during treatment: Can we visualize regional differences within the target volume using sequential diffusion weighted MRI?. Radiother Oncol 2014, 110:329-334.
40. Schakel T., Hoogduin J.M., Terhaard C.H., Philippens M.E. Diffusion weighted MRI in head-and-neck cancer: Geometrical accuracy. Radiother Oncol 2013, 109:394-397.